quantif
use
imagej
softwar
perform
c
fbl
protein
level
target
gene
encod
protein
b
e
graph
repres
mean
standard
deviat
least
experi
p
p
p
accord
student
ttest
figur
fbl
protein
level
analyz
western
blot
panel
wildtyp
mutant
breast
cell
line
fbl
lane
splice
togeth
discontinu
lane
blot
put
respons
element
primer
use
chromatin
immunoprecipit
chip
assay
shown
within
sequenc
b
ectop
express
express
analyz
western
blot
cell
luciferas
assay
c
prior
chip
assay
express
analyz
western
blot
nontreat
hme
cell
nt
camptothecintr
hme
cell
campto
cell
protein
quantif
present
upper
panel
posit
control
chip
assay
bind
gene
promot
wellknown
target
gene
analyz
qpcr
use
specif
primer
graph
repres
mean
standard
deviat
least
experi
cell
overexpress
htert
protein
hmle
overexpress
htert
tt
antigen
gener
gift
r
weinberg
elenbaa
et
al
lab
deriv
anoth
cell
line
hme
cell
stabli
express
shrna
target
addit
second
seri
human
mammari
immort
epitheli
cell
develop
verifi
data
obtain
origin
weinberg
cell
indic
hmechtert
overexpress
htert
protein
overexpress
htert
shrna
morel
et
al
mutat
statu
characteris
classic
molecular
marker
previous
determin
report
bourdon
et
al
briefli
primari
previous
untreat
oper
breast
cancer
caucasian
women
age
rang
year
median
age
year
suffici
tumor
tissu
surplu
diagnost
requir
complet
clinic
patholog
data
analyz
tabl
tumor
tissu
macrodissect
specialist
breast
pathologist
snap
frozen
liquid
nitrogen
prior
storag
sampl
examin
follow
taysid
tissu
bank
approv
deleg
author
local
research
ethic
committe
wwwtaysidetissuebankorg
immunohistochem
stain
carri
section
formalinfix
paraffinembed
tumor
mous
monoclon
antiestrogen
receptor
alpha
antibodi
progesteron
receptor
pr
antibodi
clone
mous
monoclon
antibodi
novocastra
laboratori
ltd
addit
analys
perform
accord
histolog
tumor
grade
bloom
richardson
grade
specialist
consult
breast
pathologist
estrogen
receptor
er
statu
er
neg
vs
er
posit
determin
quickscor
method
detr
et
al
score
perform
previous
describ
mutat
statu
determin
use
ng
genom
dna
extract
homogen
frozen
tissu
describ
previous
baker
et
al
use
amplichip
test
roch
diagnost
tumor
sampl
examin
rtqpcr
use
lightcycl
roch
combin
lightcycl
sybr
green
master
roch
fbl
gene
amount
target
calcul
follow
normal
fbl
express
gene
calcul
rel
fbl
express
calibr
e
e
effici
rtqpcr
reaction
calcul
slope
correspond
standard
curv
ct
threshold
cycl
ct
target
gene
ct
statist
analysi
rtqpcr
measur
perform
use
mannwhitney
test
plu
softwar
statgraph
centurion
result
judg
statist
signific
confid
level
greater
p
statist
comparison
mutat
statu
fbl
express
made
use
wilcoxon
test
pvalu
consid
statist
signific
vector
luciferas
assay
investig
whether
regul
fbl
promot
activ
pfblluc
plasmid
construct
briefli
nucleotid
sequenc
correspond
partial
exon
intron
fbl
gene
contain
two
respons
element
clone
upstream
minim
promot
vector
drive
firefli
luciferas
report
gene
luciferas
assay
transfect
effici
normalis
cotransfect
prl
construct
constitut
express
renilla
luciferas
gene
luciferas
activ
measur
luminesc
use
dualluciferas
report
assay
promega
data
given
rel
luciferas
activ
fireflyrenilla
purifi
dna
amplifi
qpcr
use
stepon
plu
appli
biosystem
faststart
univers
sybr
green
master
rox
roch
g
rpm
respect
part
cytoplasm
fraction
separ
sucros
gradient
ultracentrifug
g
hr
ribosom
distribut
along
gradient
analyz
measur
od
nm
fraction
use
nanodrop
rna
qualiti
fraction
verifi
separ
rna
agaros
gel
rna
extract
use
tripur
isol
reagent
roch
cytoplasm
fraction
polysomalpool
fraction
rna
level
quantifi
rtqpcr
describ
mrna
level
interest
normal
one
gapdh
ratio
polysom
fractioncytoplasm
fraction
calcul
take
account
variat
mrna
level
due
transcript
process
inhba
mrna
use
mrna
control
contain
ire
cell
prolifer
cell
prolifer
determin
real
time
monitor
assay
base
variat
electr
imped
xcellig
technolog
roch
briefli
cell
seed
eplat
pluggedin
rtca
real
time
cell
analysi
monitor
within
co
incub
cell
anchorag
induc
variat
electr
imped
allow
monitor
cell
prolifer
sinc
increas
electr
imped
correl
proport
increas
cell
prolifer
ke
et
al
normalis
electr
imped
hr
postseed
index
cell
prolifer
reflect
slope
growth
curv
calcul
rtca
softwar
anchorageindepend
cell
prolifer
analyz
softagar
assay
cell
suspend
complement
dmem
medium
ad
solidifi
complement
dmem
medium
cell
grown
week
paraformaldehyd
fixat
crystal
violet
color
coloni
number
count
automat
use
imagej
softwar
differenti
sensit
doxorubicin
treatment
analyz
determin
differ
clone
briefli
cell
seed
plate
hr
prior
addit
increas
concentr
doxorubicin
metabol
activ
cell
analyz
mt
assay
promega
doxorubicin
calcul
evalu
prognosi
valu
fbl
mrna
express
studi
primari
outcom
breast
cancerspecif
surviv
relapsefre
surviv
breast
cancerspecif
surviv
measur
date
diagnosi
death
censor
last
follow
accordingli
nonbreast
cancer
death
censor
time
death
ie
time
death
women
consid
surviv
breast
cancer
die
caus
relapsefre
surviv
measur
date
diagnosi
relaps
censor
last
followup
consid
relaps
tumor
diagnosi
primari
tumor
site
secondari
site
andor
metastasi
order
explor
prognost
valu
fbl
use
kaplanmei
method
fbl
express
data
first
transform
binomi
data
low
express
level
high
express
level
roc
receiv
oper
characterist
curv
use
determin
optim
cutoff
point
fbl
gene
express
ie
determin
level
fbl
gene
express
best
segreg
patient
term
surviv
accord
roc
curv
analysi
breast
tumor
sampl
fbl
gene
express
equal
defin
low
express
level
breast
tumor
sampl
fbl
gene
express
superior
defin
high
express
level
surviv
rate
estim
accord
kaplanmei
method
log
rank
test
use
assess
statist
differ
two
group
imag
quantif
western
blot
northern
blot
quantifi
use
imagej
softwar
express
level
protein
snorna
interest
normal
intern
control
total
rna
visual
ethidium
bromid
stain
sequenc
